Furthermore, the partial rescue effect in cardiac hypertrophy was also observed in the treatment of SUZ12/PRC2 inhibitors, EED226 and Boc-NH-C4-acid, during METTL5 overexpression (Figure 5K). This evidence concerns the gene SUZ12 and cardiac hypertrophy.